← TrialMatch
HomeTrials

The ASSESS National Multi-center Prospective Cohort

The ASSESS national multi-center prospective cohort (Assessment of Systemic complications (Signs) and Evolution in Sjögren's Syndrome "SS") was set up in 2006 thanks to a grant of the French Ministry of Health. Fifteen centers for autoimmune diseases consecutively included consecutive patients with Primary Sjögren's Sy

Condition(s)Primary Sjögren's Syndrome
StatusRecruiting
Study typeObservational
SummaryThe ASSESS national multi-center prospective cohort (Assessment of Systemic complications (Signs) and Evolution in Sjögren's Syndrome "SS") was set up in 2006 thanks to a grant of the French Ministry of Health. Fifteen centers for autoimmune diseases consecutively included consecutive patients with Primary Sjögren's Syndrome "pSS" fulfilling American-European Consensus Criteria (AECG) between 2006 and 2009. The study was approved by the Ethics Committee of Bichat Hospital in 2006. All patients gave their informed written consent. This study was followed for 5 years with the grant of the French Ministry of Health and this study will be extended for 20 years by French Society of Rheumatology (SFR). On an annual basis for a duration of 20 years, a thorough standardized paper case report form
Who can participateInclusion Criteria: * aged of 18 years or more * Primary Sjögren's Syndrome Patients who have already participated to the study ASSESS Exclusion Criteria: * secondary Sjögren's Syndrome (SJ) associated with other autoimmune diseases
Ages18 Years
SexAll
Lead sponsorAssistance Publique - Hôpitaux de Paris
LocationsLe Kremlin-Bicêtre, Val De Marne, France
Start date2016-09
NCT IDNCT03040583
Official listinghttps://clinicaltrials.gov/study/NCT03040583

🔍 Search all trials →